InCephalo Therapeutics

Private

Last Round

Grant

Aug 22, 2022

Total Funding Raised

$2.96M

Company Overview

InCephalo Therapeutics is a pharmaceuticals and biotechnology company that develops novel therapies for the treatment of brain cancers.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Aug 22, 2022
Accelerator	Jun 28, 2021

Notable investors and investment history

Investor	Rounds
EIT Health	Grant
Eurostars SME programme	Grant
Swiss State Secretariat for Education, Research and Innovation (SERI)	Grant
BaseLaunch	Accelerator
University of Basel	Grant

Structured signals derived from secondary market and firmographic data.

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about InCephalo Therapeutics's valuation, stock price, and market status.

HeadquartersBasel

Employee Range10

Year Founded2021

Last FundingAug 22, 2022

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.